There is an association between insulin resistance, glucose intolerance, and essential hypertension, but the relation between insulin resistance, glucose intolerance, and hypertension diagnosed during pregnancy is not well understood. Transient hypertension of pregnancy, the new-onset nonproteinuric hypertension of late pregnancy, is associated with a high risk of later essential hypertension and glucose intolerance; thus, these conditions may have a similar pathophysiology. To assess the association between insulin resistance, glucose intolerance, essential hypertension, and subsequent development of proteinuric and nonproteinuric hypertension in pregnancy in women without underlying essential hypertension , we performed a prospective study comparing glucose (fasting, 1 and 2 hours postglucose load), insulin, glycosylated hemoglobin (HbA1c), high-density lipoprotein cholesterol (HDL-C), and triglycerides levels on routine screening for gestational diabetes mellitus. Women who developed hypertension in pregnancy (n ϭ 37) had higher glycemic levels (fasting, 1 and 2 hours postglucose load) on a 100-gram oral glucose loading test, although only the fasting values showed a statistical significance (p Ͻ 0.05), and a significantly higher frequency of abnormal glucose loading tests, two hours after glucose load (Ն140 mg/dL) (p Ͻ 0.05) than women who remained normotensive (n ϭ 180). Glucose intolerance was common in women who developed both subtypes of hypertension, particularly preeclampsia. Women who developed hypertension had greater prepregnancy body mass index (p Ͻ 0.0001), higher frequency and intensity of acanthosis nigricans (p Ͻ 0.0001), and higher baseline systolic and diastolic blood pressures (p Յ 0.0001 for both), although all subjects were normotensive at baseline by study design; they also presented lower levels of HDL-C (p Ͻ 0.05). However, after adjustment for these and other potential confounders, an abnormal glucose loading test remained a significant predictor of development of hypertension (p Ͻ 0.05) and, specifically, preeclampsia (p Ͻ 0.01). There was a trend toward higher insulin and homeostasis model assessment-insulin resistance (HOMA-IR) levels in women developing any type of hypertension. When comparing women that remained normotensive to term with those with transient hypertension and preeclampsia, the preeclamptic women were born with lower weight (p Ͻ 0.05) and shorter length (p Ͻ 0.005); at screening they were older (p Ͻ 0.005), showed higher frequency and intensity of acanthosis nigricans (p Ͻ 0.0001), had higher prepregnancy BMI (p Ͻ 0.0005), as well as higher baseline systolic and diastolic blood pressures (p Յ 0.0001 for both). They also showed higher HOMA-IR levels that did not show a statistical significance. When glucose tolerance status was taken in account, an association was found between increasing indexes of hypertension (p Ͻ 0.05) and of HOMA-IR (p Ͻ 0.05) with the worsening of glucose tolerance. These results suggest that insulin resistance and relative glucose intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that insulin resistance may play a role in the pathogenesis of this disorder.
Introduction

H
YPERTENSION, A COMMON DISORDER complicating pregnancy (6-9%), remains a leading cause of maternal mortality (around 15%) in the United States 1 and worldwide. 2 Hypertension is associated with glucose intolerance and insulin resistance. 3, 4 Increased insulin resistance found in normotensive offspring of hypertensive parents 5, 6 suggests that insulin resistance may precede the development of essential hypertension and may also cause it. Possible mechanisms by which insulin resistance or hyperinsulinemia may predispose to hypertension include increased renal sodium reabsorption, 7 activation of sympathetic nervous system activity, 8 and stimulation of cell membrane cation transport. 9 Several investigators have reported insulin as a regulator of blood pressure during pregnancy, and they associated plasma insulin levels with hypertension. 10 The role of insulin resistance in the pathogenesis of hypertension arising for the first time in pregnancy is still not well understood. 11 Pregnancy is a state of increased insulin resistance 12, 13 ; hypertension in pregnancy generally presents in the third trimester when insulin resistance that normally occurs in pregnancy is higher. 14, 15 Some conditions that are associated with insulin resistance, like obesity 16 and gestational diabetes, [17] [18] [19] may be risk factors for the occurrence of hypertension in pregnancy. A role for insulin resistance in cases of new-onset hypertension in pregnancy is also suggested by the association of transient hypertension, or new-onset nonproteinuric hypertension of late pregnancy, with a high incidence of later essential hypertension. 20, 21 This study was performed to assess whether insulin resistance and glucose intolerance are associated with an increased risk of hypertension in pregnancy among women without essential hypertension, but with several degrees of glucose tolerance at the time of routine screening for gestational diabetes mellitus. Some of these women subsequently developed hypertension and some remained normotensive to term.
Methods
Subjects
The study population consisted of 217 women with singleton pregnancies, assigned to participate when the screening for gestational diabetes was performed in the third trimester, between 24 and 28 weeks of gestation, if they presented no previous or current history of hypertension. Two tests were performed to detect any degree of glucose intolerance: a 100-gram oral glucose tolerance test (OGTT) and a glycemic profile. The cutoff values for the OGTT were those proposed by Carpenter and Coustan (fasting Ն95 mg/dL; 1 hour Ն180 mg/dL; 2 hours Ն155 mg/dL; 3 hours Ն140 mg/dL) 22 and for the glycemic profile those proposed by Gillmer (fasting Ն90 mg/dL and/or 1-2 hours postprandial Ն130 mg/dL. 23 The glycemic profile was done within a week after the OGTT. Patients were taught how to measure their glycemic levels using a glucose reflectance meter in the fasting state at 8 a.m., then postprandially at 10 a.m., midday, and at 2, 4, and 6 p.m. If the results were borderline (10 mg/dL higher or lower than the cutoff values), tests were repeated. After these procedures they were classified into four groups: (1) group IA, normal OGTT and glycemic profile (normoglycemic or control group; (2) group IB, normal OGTT and abnormal glycemic profile (mild hyperglycemic group); (3) group IIA, abnormal OGTT and normal glycemic profile (gestational diabetes group); (4) group IIB, abnormal OGTT and glycemic profile (overt gestational diabetes group).
Among the women enrolled in the study, 37 presented with new-onset hypertension in index pregnancy and 180 remained normotensive to term. New-onset hypertension in pregnancy was defined as a systolic blood pressure (SBP) of 140 mmHg or greater or diastolic blood pressure (DBP) of 90 mmHg or greater, constituting a rise in SBP of 30 mmHg or greater or in diastolic blood pressure of 15 mmHg or greater over first-trimester values measured on at least two occasions more than 6 hours apart and developing after 24 weeks of gestation in a previously normotensive woman. 24 Eighteen of the hypertensive women had transient hypertension, defined as hypertension without significant proteinuria (24-hour urinary protein Ͻ300 mg); 19 women had preeclampsia, defined as hypertension in association with 24-hour urinary protein of 300 mg or greater. The normotensive control group included women who did not develop hypertension during pregnancy or in the immediate postpartum period.
To avoid inclusion of essential hypertensive women in the study, we excluded those women for which we were unable to document a normal blood pressure reading in the first trimester, or, if this was unavailable, in the 6 months preceding pregnancy or at a 6-week postpartum visit. Women were also excluded if they had any underlying medical illness, such as renal or liver disease, connective tissue disease, or diabetes antedating pregnancy, or were taking any medications that could affect glucose tolerance or blood pressure. This study was approved by the Institutional Review Board of the School of Medicine of Botucatu-São Paulo State University-UNESP, Brazil.
Data collection
Maternal characteristics, such as age, parity, ethnicity, weight and length at birth, and weight and body mass index (BMI) prepregnancy, were obtained. At screening, weight, height, blood pressure, waist and hip circumference, and hip circumference were measured. Obesity was defined as a prepregnancy BMI Ն30 kg/m 2 .
Blood samples were collected at the time the OGTT was done to determine fasting one and 2-hour postglucose load levels of glycemia, glycosylated hemoglobin (HbA1c), high-density lipoprotein cholesterol (HDL-C), triglycerides, and insulin. Blood pressure was routinely measured in all patients.
All glucose determinations were conducted using glucose oxidase method (Glucose-analyzer II Beckman, Fullerton, CA). Home blood glucose monitoring was performed with an Accu-chek Advantage II Glucometer (Roche Diagnostics GmbH, Mannheim, Germany). HDL-C and triglycerides were measured by enzymatic colorimetric assay (Vitros 250, Ortho-Clinical Diagnostics, Rochester, New York). HbA1c was determined by high-performance liquid chromatography (HPLC) (Dia-Stat analyzer, Bio-Rad Laboratories, Hercules, CA) and insulin using a specific radioimmunoassay kit (Linco Research, St. Charles, MO). Laboratory standards quality were measured routinely.
The homeostasis model assessment (HOMA-IR)was calculated to determine the degree of insulin resistance and the secretory capacity of ␤ cells, according to following equations, proposed by Mattews et al. 25 : HOMA-IR ϭ glycemia (mMol/L) ϫ insulin (U/mL)/22.5. Reference value ϭ 1.66 Ϯ 0.79; men ϭ 1.69 Ϯ 0.72; women ϭ 1.65 Ϯ 0.81; insulin resistance Ն 2.71. 26 HOMA-␤ ϭ insulin (U/mL)/glycemia (mMol/L) Ϫ 3.5. Reference value ϭ 200-250.
Statistical analysis
Means, standard deviations, and percentages were presented. Continuous data were compared among three (normotensive, transitory hypertension, and preeclampsia) or four (IA, IB, IIA, and IIB) groups using the analysis of variance (one-way, ANOVA) with Tukey posttest comparisons. Posttest for linear trend between column mean and column number was also used in some analyses. When necessary, an unpaired Student t-test or corrected Student t-test-Welch was used to compare two groups (normotensive vs. hypertensive). Discrete data among three (normotensive, transitory hypertension, and preeclampsia) or four (IA, IB, IIA, and IIB) groups were analyzed using the chi-squared test. When necessary, the Fisher exact test was used to compare the two conditions (normotensive vs. hypertensive). To detect possible correlations between independent and dependent or between two dependent variables, linear regression was applied and considered significant when r Ͼ 0.7. A p value Ͻ0.05 was considered statistically significant.
Results
Women who developed hypertension in pregnancy showed a greater prepregnancy BMI (31.05 versus 26.22 ) and higher frequency and intensity of acanthosis nigricans (77.7% versus 49.1%) (p Յ 0.001 for both) than those who remained normotensive; and although all groups had normal blood pressure at baseline as required by study entry criteria, women who developed hypertension had significantly higher baseline SBP (129.50 mmHg versus 115.10 mmHg) and DBP (83.80 mmHg versus 75.10 mmHg) than women remaining normotensive to term (p Յ 0.001 for both). Their SBP (126.20 mmHg versus 109.80 mmHg) and DBP (85.40 mmHg versus 72.40 mmHg) were also higher at 24-28 weeks of gestation when the screening was performed, than women remaining normotensive to term (p Յ 0.001 for both).They also showed higher fasting glucose (99.83 mg/dL vs. 88.86 mg/dL) and lower HDL-C levels (56.09 mg/dL vs. 63.15 mg/dL) (p Ͻ 0.05 for both). They also presented higher levels of glucose intolerance (p Ͻ 0.05); had lower birth weight, shorter birth length, were older, more frequently multiparas, had higher waist-to-hip ratio, higher levels of glycemia 1 and 2 hours postglucose load at OGTT, and higher levels of HbA1c and triglycerides, although not statistically significant (Table 1) . 40 mmHg) , respectively, than the normotensive group. They also showed higher fasting glucose (94.59 mg/dL vs. 88.86 mg/dL) and lower HDL-C levels (50.59 mg/dLvs. 63.15 mg/dL) (p Ͻ 0.05 for both). They were younger, had shorter stature, were more frequently multiparas, had greater weight gain, higher waist-to-hip ratio, higher 1-hour and lower 2-hour levels of glucose postload, and higher levels of HbA1c and triglycerides that were not statistically significant.
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Patients , respectively (p Յ 0.001 for both). They also showed higher fasting glucose levels (105.06 mg/dL versus 88.86 mg/dL) than the normotensive group (p -0.05 for both). They were taller, had higher parity, greater weight gain, higher waist-to-hip ratio, higher levels of glycemia 1 hour and 2 hours postglucose load, and higher levels of HbA1c and triglycerides that also showed no statistical significance (Table 2) .
Insulin levels measured at the time OGTT was performed tended to be higher among women who developed hypertension in pregnancy (16.25 U/mL) than among those who remained normotensive (12.80 U/mL), although without statistical significance; but HOMA-IR levels (3.55 vs. 2.40) showed statistical significance between the two groups (p Ͻ 0.05) ( Table 3) . When the hypertensive groups were analyzed separately, the group with preeclampsia presented the highest insulin levels, followed by the transient hypertension and the normotensive groups (16.80 U/mL vs. 15.70 U/mL vs. 12.80 U/mL), respectively; also the highest levels of HOMA- (Table 4) . Taking in account two diagnostic methods, the 100-gram OGTT and the glycemic profile to determine glucose tolerance status, women that presented new-onset hypertension in pregnancy belonged significantly to the more glucose-intolerant groups when compared to the normotensive women (7.55%, IA; 13.79%, IB; 22.00%, IIA; and 23.26%, IIB; vs. 92.45%, IA; 86.21%, IB; 78.00%, IIA; 76.74%, IIB), respectively (p ϽϽ 0.05). The same trend was observed when patients were analyzed by subtypes of hypertension; transient hypertension was more frequently found in the group presenting mild gestational hyperglycemia (IB) and preeclampsia in the gestational diabetes (IIA) (p Ͻ 0.05)( Table 4 ).
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No absolute fasting glucose level distinguished reliably between women developing new-onset hypertension in pregnancy and normotensive women. Still, a significantly higher percentage of women who developed hypertension (43.24%) than remained normotensive (27.80%) had OGTT glucose levels of 140 mg/dL or greater, 2 hours after glucose load (p Ͻ 0.05); particularly women developing preeclampsia (57.89%) had glucose levels in this range (p Ͻ 0.05) Using a muitivariate analysis to assess the risk for new-onset hypertension in pregnancy associated with an OGTT glucose level of 140 mg/dL or greater, 1 or 2 hours after glucose load, and after adjustment for maternal age, race (Caucasian versus non-Caucasian), and gestational age at OGTT, high glucose levels both in fasting, 1 hour and 2 hours postglucose load were associated with a significantly increased risk of hypertension (p Ͻ 0.05).
Discussion
Insulin resistance is associated with and may be causal in essential hypertension. 4, 5, [7] [8] [9] The results of the present study indicate a strong association between glucose intolerance, insulin resistance, and subsequent development of hypertension in pregnancy, particularly the preeclampsia subtype. Glucose tolerance was evaluated before the development of hypertension, and it was found that relative glucose intolerance may precede the onset of this disorder. Women with insulin-dependent diabetes antedating pregnancy are known to have an increased risk of hypertension in pregnancy, 27 but these women primarily have insulin deficiency rather than insulin resistance, and they often have renal dysfunction that might underlie blood pressure elevation. More recently, risk of hypertension in pregnancy has been reported by some, 18, [28] [29] [30] [31] although not all 32, 33 investigators to be increased among women with gestational diabetes, a disorder associated with underlying insulin resistance. 34 Some, 31, 35 but not other, 18 studies have suggested a relation between less-striking degrees of glucose intolerance and subsequent hypertension in pregnancy.
The present study carefully excluded preexisting essential hypertension by documentation of normal blood pressures before, early in pregnancy, and after the pregnant state. Although not uncommon during the reproductive years, essential hypertension is often undiagnosed in this population; many women do not routinely see a physician before pregnancy, and they may not receive obstetric care until the second trimester of pregnancy, when there is a normal physiological decrease in blood pressure. Confirmation of previous or subsequent normotension among women diagnosed with hypertension in pregnancy in the present study eliminates the possibility that the glucose intolerance noted in these women could be explained by misclassification of women with preexisting essential hypertension. We also distinguished between subtypes of hypertension in pregnancy and observed a significantly higher frequency of glucose intolerance (abnormal OGTTs) among women who developed any type of hypertension. The increased incidence of later essential hypertension reported among women with transient hypertension and preeclampsia 36 is consistent with this observation. Significant associations were also found between new-onset hypertension in pregnancy and prepregnancy BMI and blood pressures earlier in pregnancy. These observations are consistent with previously reported associations between hypertension in pregnancy and obesity, 15, 37 and excessive pregnancy weight gain 16 and blood pressure in the second trimester or earlier. 38 The greater BMIs noted among women who are subsequently diagnosed with preeclampsia may reflect early evidence of the edema characteristic of this disorder or, alternatively, could be pathogenic.
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The observation of higher first-trimester blood pressures in initially normotensive women who subsequently develop transient hypertension suggests an underlying tendency to high blood pressure in these women that is unmasked or exaggerated by pregnancy. Underlying essential hypertension is considered a risk factor for development of preeclampsia 21, 24 ; our observation of higher baseline blood pressures among women developing this disorder indicates that relative increases in blood pressure within the normal range are also associated with increased risk of developing the disease.
The relation between glucose tolerance and subsequent development of hypertension in pregnancy remained significant in our population after adjustment for maternal age, race, gestational age at OGTT, and prepregnancy BMI. The trend toward higher insulin levels in women who developed hypertension in pregnancy, although not statistically significant, nevertheless suggests a role for insulin resistance or hyperinsulinemia in the pathogenesis of this disorder. A link between insulin resistance and development of hypertension in pregnancy is also supported by the association of hypertension in pregnancy with increased BMI in this and other studies. 15, 21, 24 The finding of an association between mild degrees of hyperglycemia (group IB) and higher incidence of transient hypertension suggest that even slightly higher levels of insulin are associated with an increased risk for developing these conditions. 31 Some investigators consider primigravidity to be a criterion for the diagnosis of preeclampsia 36 ; however, primigravidas (27.03%) in our study were less frequently diagnosed with transient hypertension and preeclampsia than multigravidas (72.97%).
In summary, our results indicate that glucose intolerance may be an important predictor of the development of new-onset hypertension in pregnancy. These data provide support for the hypothesis that insulin resistance may have a role in the pathogenesis of hypertension in pregnancy.
